Altria Group was downgraded to hold following a post-earnings correction and technical consolidation below its 50-day moving average. The company's Q2 2026 results were mixed, with smokeable products showing resilience but oral tobacco sales declining 5.2% year-over-year, raising concerns about segment momentum. Despite this, Altria's valuation remains attractive with a forward P/E of about 12x and a dividend yield around 6.17%. However, dividend growth has slowed to 3.77% year-over-year, reflecting ongoing growth pressures in the business.
The Schwab U.S. Dividend Equity ETF (SCHD) underwent its annual March reconstitution, replacing 22 stocks with 25 new ones, notably increasing holdings in semiconductors and energy sectors. This reshuffle altered the dividend profile and sector expos...
Altria has stabilized its smokeable tobacco earnings and market share through value-oriented cigarette launches and is expanding its nicotine pouch segment with the on! brand. The company benefits from strong cash flows, a healthy balance sheet, and ...
Altria reported mixed Q2 results but raised the lower end of its full-year 2026 EPS guidance and announced a dividend increase, maintaining a high 6.45% yield. The company also signed a new manufacturing agreement with Philip Morris to optimize produ...
Altria Group continues to be an attractive income investment, yielding 6.4% after raising its dividend for the 57th consecutive year. The company showed robust Q2 2026 financial results, supported by strong pricing power, high profit margins in its s...
